Hepatitis: all 3,372 studies
Page 17 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Observational Study on Pregnant Women With Chronic Hepatitis B and Their InfantsStatus unknownNCT03539016
- DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)CompletedNCT03537196Phase 4
- Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With LeukemiaStatus unknownNCT03529760
- The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With IbrutinibCompletedNCT03528941
- DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject DrugsCompletedNCT03526939
- Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms.Status unknownNCT03524014
- HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102Status unknownNCT03519113Phase 2/3
- Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell TransplantCompletedNCT03511794
- "Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in EgyptStatus unknownNCT03510637
- The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical TrialCompletedNCT03509688Not applicable
- Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)TerminatedNCT03500562
- Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected PatientsCompletedNCT03496233Phase 3
- Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral InfectionsStatus unknownNCT03495570
- A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgramsCompletedNCT03492112Not applicable
- Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir CombinationCompletedNCT03490097Phase 2/3
- Entecavir to TAF SwitchActive, not recruitingNCT03489239Phase 3
- HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for LiverStatus unknownNCT03488589
- Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab ModelStatus unknownNCT03488485Not applicable
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1bCompletedNCT03485846Phase 2
- Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B PatientsCompletedNCT03485534Phase 4
- Re-treatment of HCV Following DAA FailureTerminatedNCT03483987Not applicable
- Crowdsourcing to Promote HBV and HCV Testing in ChinaCompletedNCT03482388Not applicable
- DAA Therapy in Pediatric Patients With Chronic Hepatitis CStatus unknownNCT03481036Not applicable
- Monitoring the IMmUological TOXicity of DrugsCompletedNCT03480529
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical TransmissionStatus unknownNCT03476083Phase 4
- Pathology of Hepatitis c NephropathyStatus unknownNCT03476031
- The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedNCT03468907Phase 4
- International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife)CompletedNCT03468673
- A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically SuppressedCompletedNCT03463369Phase 1
- Cohort Study on People Who Inject Drugs in SenegalStatus unknownNCT03459768
- Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.CompletedNCT03459521Not applicable
- The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver CirrhosisStatus unknownNCT03456440
- Incidence Of Hepatitis In Intensive Care UnitStatus unknownNCT03456037
- Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis CCompletedNCT03453346Not applicable
- Effect of Direct-acting Antiviral Drugs on Erectile FunctionStatus unknownNCT03444272Phase 3
- Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial HospitalTerminatedNCT03441542Not applicable
- Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western ChinaStatus unknownNCT03435406
- Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis BStatus unknownNCT03429439Not applicable
- A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis BCompletedNCT03426618
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfectionStatus unknownNCT03425994
- Hepatitis B Virus Prevalence and Risk Factors in BelgiumCompletedNCT03425513
- The Staying Safe InterventionStatus unknownNCT03418636Not applicable
- Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis CCompletedNCT03416491Phase 2
- Hepatitis B Vaccine for Non-respondersCompletedNCT03415672Phase 2
- Effect of Implementation Of Outreach Behavioral Change Program for HCV EliminationCompletedNCT03415334Not applicable
- Prevalence of IL28B Polymorphism in Hepatitis C PatientsCompletedNCT03415009
- Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected PatientsCompletedNCT03413696
- Hepatitis C (HCV) Cure and Kidney HealthStatus unknownNCT03407703
- HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAgStatus unknownNCT03405597Phase 3
- Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk FactorsCompletedNCT03402334Not applicable
- Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis CStatus unknownNCT03402165Phase 4
- Eliminating Hepatitis C VirusCompletedNCT03401697
- Hepatitis B Prevalence in the Turkish Population Living in Middle LimburgStatus unknownNCT03396458
- Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4WithdrawnNCT03381859Phase 4
- Expanding the Pool in Lung TransplantationCompletedNCT03377478Phase 1
- Impact of Chlordecone on Active Chronic HepatitisCompletedNCT03373396Not applicable
- Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency VirusCompletedNCT03369327Phase 3
- Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based RegimensCompletedNCT03366610
- Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral TherapyStatus unknownNCT03366571
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)CompletedNCT03365921Phase 4
- Toward Elimination of Hepatitis C Virus (HCV): A Pilot StudyStatus unknownNCT03364725Phase 4
- Epidemiology of Hepatitis B, C and Delta in Reunion IslandStatus unknownNCT03362866
- Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney TransplantStatus unknownNCT03359746Phase 4
- A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study)Status unknownNCT03358108
- A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis BStatus unknownNCT03357822Phase 4
- Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDFCompletedNCT03356834Phase 4
- HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue TherapyCompletedNCT03350074
- Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownNCT03349008Phase 4
- Side Effects After Direct-acting Antiviral TreatmentCompletedNCT03346941
- Entecavir for Decompensated HBV CirrhosisCompletedNCT03345498
- Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based SettingsCompletedNCT03343925
- Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C AdolescentsStatus unknownNCT03343444Phase 3
- Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B InfectionActive, not recruitingNCT03343431Phase 3
- Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed CryoglobulinemiaCompletedNCT03342261
- Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6CompletedNCT03341871
- Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B PatientsStatus unknownNCT03332329Phase 4
- Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A VaccineStatus unknownNCT03330171Phase 4
- Quality of Life and Health Utility of Patients With CHB InfectionsCompletedNCT03329820
- Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCVCompletedNCT03324633
- Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2CompletedNCT03320889Not applicable
- EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT03320616Phase 1
- Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNACompletedNCT03318887
- Hepatitis C Screening in the Primary Care SettingCompletedNCT03316313
- HCV Post-Exposure Prophylaxis for Health Care WorkersWithdrawnNCT03313414Phase 4
- Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-relatedCompletedNCT03313154
- Effects of Aging on Primary and Secondary Vaccine ResponsesCompletedNCT03312699Phase 1
- ID HBV Vaccination With Imiquimod in OBICompletedNCT03307902Phase 2/3
- Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6CompletedNCT03303599
- Biologic Basis of Liver Cancer From Chronic Hepatitis BCompletedNCT03300414
- Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B PatientCompletedNCT03294798Phase 1/2
- A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion RatesCompletedNCT03293576Not applicable
- Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in BordeauxCompletedNCT03290755
- HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)CompletedNCT03282474Phase 2
- Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral DrugsStatus unknownNCT03268317
- Detection of Hepatitis C Infection by Oraquick Test Among Health Care WorkersStatus unknownNCT03254901
- Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological ResponseCompletedNCT03254121
- A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus InfectionTerminatedNCT03253471Phase 1
- Integrating HIV and Hepatitis C Screening in an Urban Emergency DepartmentCompletedNCT03252483Not applicable
- Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected PatientsCompletedNCT03250910Phase 4
- Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative RecipientsCompletedNCT03249194Early Phase 1